What is the primary therapeutic goal of calcium supplements for someone with DiGeorge's syndrome?

The primary therapeutic goal of calcium supplements for individuals with DiGeorge's syndrome is to prevent tetany. DiGeorge's syndrome often leads to hypoparathyroidism, which results in low calcium levels in the body. Calcium plays a crucial role in various physiological processes, including maintaining normal muscle function and neuromuscular excitability.

Tetany is characterized by muscle spasms or cramps, especially in the hands and feet, and it occurs when calcium levels drop too low. By supplementing calcium, health care providers aim to stabilize calcium levels in the blood, thereby preventing the occurrence of tetany and its associated symptoms. This therapeutic strategy is important in managing the clinical manifestations of DiGeorge's syndrome and promoting normal muscle and nerve function.

Other options, while related to calcium levels, do not represent the primary focus of calcium supplementation within this context. Improved muscular contractions can occur with balanced calcium levels, but the direct prevention of tetany is the main goal. Decreased heart rate and increased bowel sounds are not specific therapeutic outcomes sought through calcium supplementation. Thus, the primary aim remains centered on preventing tetany in individuals with this syndrome.